公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2022 | Potential Therapeutic Strategy for EGFR-Mutant Lung Cancer With Concomitant EML4-ALK Rearrangement-Combination of EGFR Tyrosine Kinase Inhibitors and ALK Inhibitors | Huang, Ming-Hung; JIH-HSIANG LEE ; Hung, Pei-Shan; Chih-Hsin Yang, James | JTO clinical and research reports | 2 | 0 |